Kintara Therapeutics Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits, Leadership Update, Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Material Modification to Rights of Security Holders, Changes in Control of Registrant